

Job Seekers, Welcome to ASHP CareerPharm
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Boca Raton Regional Hospital
Boca Raton, Florida
Miami Cancer Institute at Baptist Health
Miami, Florida
Miami Cancer Institute at Baptist Health
Miami, Florida
Baptist Health South Florida
Miami Lakes, Florida
Featured! Featured!
Cape Fear Valley Health System
Fayetteville, North Carolina
Cape Fear Valley Health
Fayetteville, North Carolina
Cape Fear Valley Health System
Fayetteville, North Carolina
Novant Health New Hanover Regional Medical Center
Wilmington, North Carolina
Novant Health New Hanover Regional Medical Center
Wilmington, North Carolina
West Virginia University Medicine - WVU Hospitals
Morgantown, West Virginia
Featured! Featured!
FirstHealth of the Carolinas
Pinehurst, North Carolina
Featured! Featured!
Featured! Featured!
Featured! Featured!
University of Rochester Medical Center
Rochester, New York
East Tennessee State University Bill Gatton College of Pharmacy
Johnson City, Tennessee
Saskatchewan Health Authority
Prince Albert, Saskatchewan, Canada
University of Rochester Medical Center
Rochester, New York
Loading... Please wait.
MCPHS University / Novartis – Regulatory Affairs, Post PharmD Fellowship
Novartis BioMedical Research, in collaboration with MCPHS, offers a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. The Novartis fellow will gain extensive experiences through various practical activities in both industry and academic settings, which could enhance the potential for accelerated career development. The Regulatory Affairs Early Development (RA ED) department at Novartis is responsible for providing global strategic regulatory guidance to advance a diverse portfolio of compounds through the early phases of clinical research from first-in-human (FIH) Phase I trials through proof-of-concept (PoC) Phase IIa studies. RA ED supports programs across Oncology, Hematology, Non-Malignant Hematology and a
Loading. Please wait.
Powered By
